A one-dose oral drug called zoliflodacin has proven highly effective against gonorrhoea in a major international trial. The pill matched the success of current treatments while avoiding injections and complex dosing. As antibiotic resistance spreads, this new option could make treatment simpler and more accessible worldwide. Approval could mark a major step forward in controlling a stubborn global STI.
View the full article